Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease
Each year, the incidence of nonalcoholic fatty liver (NAFLD) disease increases. NAFLD is a chronic disease. One of the most common causes of NAFLD is an inadequate lifestyle, which is characterized by a lack or low physical activity and eating highly processed foods rich in saturated fat and salt an...
Saved in:
Main Authors: | Sara Jarmakiewicz-Czaja, Aneta Sokal, Piotr Pardak, Rafał Filip |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2022/4344905 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Influence of Nutrients on Inflammatory Bowel Diseases
by: Sara Jarmakiewicz-Czaja, et al.
Published: (2020-01-01) -
Overview of Newer Glucocorticosteroid Preparations for Inflammatory Bowel Disease
by: R Brattsand
Published: (1990-01-01) -
The use of oral topically acting glucocorticosteroids in the treatment of
inflammatory bowel disease
by: P. Rutgeerts
Published: (1998-01-01) -
Glucocorticosteroid in Treatment of Severe Pneumonia
by: Felinda Ariani, et al.
Published: (2013-01-01) -
Cancer Risk in Inflammatory Bowel Disease
by: Anders M Ekbom
Published: (1995-01-01)